(Q37621550)

21 August 2017

1 reference

title

Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts (English)

1 reference

stem cell transplantation

21 August 2017

main subject

1 reference

Dorothy McCoy

1

1 reference

21 August 2017

Daryl D Depestel

series ordinal

2

1 reference

21 August 2017

Peggy L Carver

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

29

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1306-1325

1 reference

Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Risk factors for the development of invasive fungal infections in allogeneic blood and marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Invasive mold infections in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Antifungal serum concentration monitoring: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Voriconazole therapeutic drug monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Cyclophosphamide metabolism is affected by azole antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Update on invasive aspergillosis: clinical and diagnostic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Pharmacology of Systemic Antifungal Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.11.1306

Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1097/FTD.0B013E3181898B0C

Identifiers

DOI

10.1592/PHCO.29.11.1306

1 reference

21 August 2017

1 reference